Benoit Chabot, PhD

Département de microbiologie et d’infectiologie, Faculté de médecine et des sciences de la santé, Université de Sherbrooke (Canada)

A novel class of CLK inhibitors that preferentially target SRSF10 and promote p53-dependent cytotoxicity on human colorectal cancer cells.

Ruth Sperling, PhD

Department of Genetics, The Hebrew University of Jerusalem, Jerusalem (Israel)

Quality control of splicing regulation.

Steve Wilton, PhD

MURDOCH UNIVERSITY (AUSTRALIA)

Therapeutic alternative splicing: applications to human inherited diseases

Biochemistry and Molecular Biology, Faculty of Medicine, The Hebrew University (Israel)

Lorna Harries, PhD

University of Exeter Medical School, Exeter (UK)

Dysregulation of alternative splicing; a new hallmark of ageing?

Yi Xing, PhD

Director, Center for Computational and Genomic Medicine The Children’s Hospital of Philadelphia (USA)

Alternative splicing in cancer transcriptomes.

Frans Cremers, PhD

Department of Human Genetics, Radboud University Medical Center, Nijmegen (The Netherlands)

Stargardt disease-associated deep-intronic variants in ABCA4 result in complex splicing defects.